Repligen (RGEN) Other Non Operating Income (2012 - 2026)
Repligen (RGEN) posted quarterly Other Non Operating Income of -$273000.0 for Q2 2026, down 107.8% year-over-year from $3.5 million in Q2 2025, and up 63.6% quarter-over-quarter from -$750000.0 in Q1 2026.
Repligen (RGEN) Other Non Operating Income (2012 - 2026) Analysis & Trends
Repligen (RGEN) has reported Other Non Operating Income for 15 consecutive years, with -$273000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Non Operating Income fell 107.8% year-over-year to -$273000.0; the TTM figure through Jun 2026 stood at -$1.4 million (down 179.42% YoY), while the FY2025 annual figure was $2.8 million, up 154.41% from the prior year.
- Other Non Operating Income improved to -$273000.0 in Q2 2026 per RGEN's latest filing, from -$750000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $3.5 million in Q2 2025 and bottomed at -$14.2 million in Q4 2023.
- Historically, Other Non Operating Income has averaged -$1.4 million across 5 years, with a median of -$279500.0 in 2025.
- Annual changes were most pronounced in 2024 — Other Non Operating Income plunged 4692.21% — and 2025, when it soared 1728.84%.
- Repligen's Other Non Operating Income stood at $858000.0 in 2022, then slumped by 1752.21% to -$14.2 million in 2023, then jumped by 68.07% to -$4.5 million in 2024, then jumped by 108.9% to $403000.0 in 2025, then sank by 167.74% to -$273000.0 in 2026.
- Business Quant data shows RGEN's Other Non Operating Income at -$273000.0 in Q2 2026, -$750000.0 in Q1 2026, and $403000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -273,000.00 |
| Mar 31, 2026 | -750,000.00 |
| Dec 31, 2025 | 403,000.00 |
| Sep 30, 2025 | -804,000.00 |
| Jun 30, 2025 | 3.50 Mn |
| Mar 31, 2025 | -286,000.00 |
| Dec 31, 2024 | -4.53 Mn |
| Sep 30, 2024 | 3.10 Mn |
| Jun 30, 2024 | -215,000.00 |
| Mar 31, 2024 | -3.54 Mn |
| Dec 31, 2023 | -14.18 Mn |
| Sep 30, 2023 | 895,000.00 |
| Jun 30, 2023 | 528,000.00 |
| Mar 31, 2023 | 77,000.00 |
| Dec 31, 2022 | 858,000.00 |
| Sep 30, 2022 | -6.59 Mn |
| Jun 30, 2022 | -3.40 Mn |
| Mar 31, 2022 | -402,000.00 |
| Dec 31, 2021 | -7.26 Mn |
| Sep 30, 2021 | -786,000.00 |